Man Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.7M | Buy |
330,889
+169,073
| +104% | +$16.2M | 0.05% | 368 |
|
|
2025
Q4 | $15.5M | Buy |
161,816
+87,777
| +119% | +$8.53M | 0.03% | 612 |
|
|
2025
Q3 | $7.05M | Sell |
74,039
-16,720
| -18% | -$1.54M | 0.01% | 942 |
|
|
2025
Q2 | $7.91M | Sell |
90,759
-153,002
| -63% | -$13M | 0.02% | 868 |
|
|
2025
Q1 | $21.9M | Sell |
243,761
-460,818
| -65% | -$41.2M | 0.06% | 407 |
|
|
2024
Q4 | $56.3M | Buy |
704,579
+367,920
| +109% | +$31.8M | 0.15% | 158 |
|
|
2024
Q3 | $30.3M | Sell |
336,659
-272,238
| -45% | -$22.9M | 0.08% | 313 |
|
|
2024
Q2 | $47.9M | Buy |
608,897
+191,561
| +46% | +$15.7M | 0.12% | 185 |
|
|
2024
Q1 | $36.4M | Buy |
417,336
+212,583
| +104% | +$18.1M | 0.09% | 256 |
|
|
2023
Q4 | $16.9M | Buy |
+204,753
| New | +$15.6M | 0.05% | 455 |
|
|
2023
Q3 | – | Sell |
-294,246
| Closed | -$24.6M | – | 444 |
|
|
2023
Q2 | $25.9M | Buy |
+294,246
| New | +$25.3M | 0.08% | 310 |
|
|
2023
Q1 | – | Sell |
-469,901
| Closed | -$38.3M | – | 417 |
|
|
2022
Q4 | $36.5M | Buy |
469,901
+235,581
| +101% | +$19.1M | 0.13% | 195 |
|
|
2022
Q3 | $18.9M | Buy |
+234,320
| New | +$21.1M | 0.09% | 272 |
|
|
2022
Q2 | – | Sell |
-291,056
| Closed | -$29.5M | – | 289 |
|
|
2022
Q1 | $32.3M | Sell |
291,056
-158,766
| -35% | -$16.8M | 0.11% | 199 |
|
|
2021
Q4 | $46.5M | Buy |
449,822
+18,762
| +4% | +$2.17M | 0.15% | 148 |
|
|
2021
Q3 | $54M | Sell |
431,060
-70,049
| -14% | -$9.07M | 0.19% | 118 |
|
|
2021
Q2 | $62.2M | Buy |
501,109
+9,625
| +2% | +$1.21M | 0.22% | 96 |
|
|
2021
Q1 | $58.1M | Buy |
491,484
+110,056
| +29% | +$12.9M | 0.26% | 85 |
|
|
2020
Q4 | $44.7M | Sell |
381,428
-282,313
| -43% | -$31.1M | 0.2% | 102 |
|
|
2020
Q3 | $69M | Buy |
663,741
+49,207
| +8% | +$4.94M | 0.27% | 75 |
|
|
2020
Q2 | $56.4M | Sell |
614,534
-116,016
| -16% | -$11.1M | 0.28% | 70 |
|
|
2020
Q1 | $65.9M | Sell |
730,550
-435,338
| -37% | -$46.3M | 0.43% | 44 |
|
|
2019
Q4 | $132M | Sell |
1,165,888
-136,697
| -10% | -$15M | 0.44% | 41 |
|
|
2019
Q3 | $141M | Sell |
1,302,585
-505,347
| -28% | -$52.7M | 0.53% | 30 |
|
|
2019
Q2 | $176M | Sell |
1,807,932
-509,240
| -22% | -$46.5M | 0.64% | 17 |
|
|
2019
Q1 | $211M | Buy |
2,317,172
+57,150
| +3% | +$5.12M | 0.8% | 11 |
|
|
2018
Q4 | $206M | Buy |
2,260,022
+59,816
| +3% | +$5.59M | 0.91% | 14 |
|
|
2018
Q3 | $216M | Buy |
2,200,206
+1,469,757
| +201% | +$136M | 0.79% | 14 |
|
|
2018
Q2 | $62.5M | Sell |
730,449
-214,458
| -23% | -$17.9M | 0.26% | 60 |
|
|
2018
Q1 | $75.8M | Buy |
+944,907
| New | +$77.9M | 0.35% | 48 |
|
Other funds holding MDT
VCM
VPM
Man Group's MDT Position: Q1 2026 in Review
Man Group increased its Medtronic (MDT) stake by 104% in Q1 2026, buying an estimated $16.2M and bringing the position to 330,889 shares worth $28.7M. The position accounts for 0.05% of the portfolio, ranked #368.
Man Group first reported a position in MDT in Q1 2018 and has held it in 30 quarters since. The position peaked at $216M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Man Group held 330,889 shares of Medtronic worth $28.7M as of Q1 2026.
- Man Group bought 169,073 Medtronic shares in Q1 2026, an estimated $16.2M.
- Medtronic made up 0.05% of Man Group's portfolio in Q1 2026, its #368 holding.
- Man Group first reported a position in Medtronic in Q1 2018 and has held it in 30 quarters since.
- Man Group's Medtronic position peaked at $216M in Q3 2018.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.